Purity, aggregation state, and target binding are critical quality requirements that need to be monitored throughout the antibody development cycle as they impact product efficacy and safety. Yet, ...

ANTIBODY TITRATION is critical to the success of any flow cytometry experiment. This is even more so in microflow cytometric analysis of extracellular vesicles (EVs), where removing excess antibodies ...

In this webinar, presented in association with the journal mAbs, Drs. Crescioli and Reichert discuss recent trends in antibody therapeutics development and forecast key events that may occur in 2026.

Novel or next-generation biologics such as bispecific antibodies (bsAbs) and fusion proteins present unique development and manufacturing process challenges due to complex formats, suboptimal ...

Static and dynamic light scattering are invaluable tools for quantifying protein-protein interactions and aggregation phenomena. This webinar will review light scattering-based methods for protein ...

In this webinar, brought to you by The Antibody Society (MA, USA), in association with the journal mAbs, Drs. Crescioli and Reichert discuss the recent trends in antibody therapeutics development ...

Antibodies, as powerful therapeutic agents, have demonstrated immense potential in treating a range of diseases, from cancer to infectious diseases. Recent advances in artificial intelligence (AI) and ...

Antibody therapeutics is a fast-growing market boosted by developments in bispecific antibodies and in newly emerging tetra-specific antibodies. With the ability to recruit a combination of antibody ...

When confirming antibody concentrations, sizing up proteins, or seeking the perfect formulation for a next-gen biologic, traditional approaches leave researchers tied to the lab bench for way too long ...

Ikoma, Japan – Antibodies (immunoglobulins) are Y-shaped proteins that recognize and neutralize specific pathogens. Their ability to target specific molecules or cells has made them promising ...